Effects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People With Schizophrenia

Clinical trial NCT00218218 · COMPLETED

Trial details

NCT number: NCT00218218
Sponsor: National Institute on Drug Abuse (NIDA)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Schizophrenia and Disorders With Psychotic Features Tobacco Use Disorder Schizophrenia

Start date: 2002-06-01
Primary completion: 2005-02-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.